Otsuka and Ionis Pharmaceuticals partner for Hereditary Angioedema Treatment

December 22, 2023

Promising Results from Gelesis Study Show Stomach-Filling Capsule as Potential Alternative to GLP-1s for Weight Loss

July 1, 2023

BeOne Announces $950M Royalty Deal For Amgen’s Imdelltra

August 31, 2025

Must Read

Contineum, J&J Drug Shows Poor Results in Multiple Sclerosis Trial

November 24, 2025

J&J Ends Phase 2 Alzheimer’s Study After Posdinemab Fails to Slow Decline

November 24, 2025

FDA Approves Bayer’s Hyrnuo for HER2-Mutated Non-Small Cell Lung Cancer

November 24, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Contineum, J&J Drug Shows Poor Results in Multiple Sclerosis Trial

J&J Ends Phase 2 Alzheimer’s Study After Posdinemab Fails to Slow Decline

Neurocrine’s Depression Drug Encounters Surprising Phase II Failure

Alixorexton Shows Mixed Efficacy in Mid-Stage Narcolepsy Type 2 Trial

FDA Approves Bayer’s Hyrnuo for HER2-Mutated Non-Small Cell Lung Cancer

Artios Pharma Raises $115 Million to Advance DDR-Focused Oncology Pipeline

Lyell to pay $40M For Colorectal Cancer CAR-T Therapy

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

News

China forces insulin price cuts resulting in pullback for global pharma players

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

Sanofi to acquire Origimm Biotechnology in a bid to expand vaccine pipeline

Is Biogen’s Alzheimer’s drug worth $56K? Experts say $8400 and raise questions about efficacy

AstraZeneca and FibroGen hit FDA committee’s safety data firewall for roxadustat

NRx Pharmaceuticals signs deal for clinical trials of Israel’s homegrown Covid-19...

Editor Picks

Otsuka and Ionis Pharmaceuticals partner for Hereditary Angioedema Treatment

Promising Results from Gelesis Study Show Stomach-Filling Capsule as Potential Alternative to GLP-1s for Weight Loss

BeOne Announces $950M Royalty Deal For Amgen’s Imdelltra

Must Read

Contineum, J&J Drug Shows Poor Results in Multiple Sclerosis Trial

J&J Ends Phase 2 Alzheimer’s Study After Posdinemab Fails to Slow Decline

FDA Approves Bayer’s Hyrnuo for HER2-Mutated Non-Small Cell Lung Cancer

Hot Topics

About Us

Follow Us